High Net Worth Advisory Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$401K Hold
1,900
0.09% 164
2025
Q4
$390K Sell
1,900
-200
-10% -$37.6K 0.09% 162
2025
Q3
$330K Hold
2,100
0.08% 175
2025
Q2
$353K Hold
2,100
0.09% 162
2025
Q1
$289K Hold
2,100
0.08% 171
2024
Q4
$248K Hold
2,100
0.07% 188
2024
Q3
$232K Hold
2,100
0.06% 203
2024
Q2
$206K Hold
2,100
0.06% 205
2024
Q1
$235K Buy
+2,100
New +$227K 0.07% 188
2023
Q4
Sell
-2,750
Closed -$239K 199
2023
Q3
$239K Sell
2,750
-395
-13% -$35.7K 0.1% 162
2023
Q2
$297K Sell
3,145
-255
-8% -$21.5K 0.12% 143
2023
Q1
$257K Sell
3,400
-1,000
-23% -$75.4K 0.1% 157
2022
Q4
$338K Sell
4,400
-1,800
-29% -$137K 0.13% 137
2022
Q3
$413K Hold
6,200
0.18% 116
2022
Q2
$324K Hold
6,200
0.13% 136
2022
Q1
$352K Hold
6,200
0.13% 133
2021
Q4
$319K Buy
+6,200
New +$304K 0.11% 152

Other funds holding CAH

High Net Worth Advisory Group's CAH Position: Q1 2026 in Review

High Net Worth Advisory Group held its Cardinal Health (CAH) position steady in Q1 2026 at 1,900 shares worth $401K. The position accounts for 0.09% of the portfolio, ranked #164.

High Net Worth Advisory Group first reported a position in CAH in Q4 2021 and has held it in 17 quarters since. The position peaked at $413K in Q3 2022. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • High Net Worth Advisory Group held 1,900 shares of Cardinal Health worth $401K as of Q1 2026.
  • High Net Worth Advisory Group left its Cardinal Health share count unchanged in Q1 2026.
  • Cardinal Health made up 0.09% of High Net Worth Advisory Group's portfolio in Q1 2026, its #164 holding.
  • High Net Worth Advisory Group first reported a position in Cardinal Health in Q4 2021 and has held it in 17 quarters since.
  • High Net Worth Advisory Group's Cardinal Health position peaked at $413K in Q3 2022.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on High Net Worth Advisory Group's 13F filing for Q1 2026, filed 17 Apr 2026.